rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2007-10-5
|
pubmed:abstractText |
Graft-versus-host disease (GVHD) continues to be a serious complication that limits the success of allogeneic bone marrow transplantation (BMT). Using IL-7-deficient murine models, we have previously shown that IL-7 is necessary for the pathogenesis of GVHD. In the present study, we determined whether GVHD could be prevented by antibody-mediated blockade of IL-7 receptor alpha (IL-7Ralpha) signaling. C57/BL6 (H2K(b)) recipient mice were lethally irradiated and underwent cotransplantation with T-cell-depleted (TCD) BM and lymph node (LN) cells from allogeneic BALB/c (H2K(d)) donor mice. Following transplantation, the allogeneic BMT recipients were injected weekly with either anti-IL-7Ralpha antibody (100 mug per mouse per week) or PBS for 4 weeks. Anti-IL-7Ralpha antibody treatment significantly decreased GVHD-related morbidity and mortality compared with placebo (30% to 80%). IL-7Ralpha blockade resulted in the reduction of donor CD4(+) or CD8(+) T cells in the periphery by day 30 after transplantation. Paradoxically, the inhibition of GVHD by anti-IL-7Ralpha antibody treatment resulted in improved long-term thymic and immune function. Blockade of IL-7R by anti-IL-7Ralpha antibody resulted in elimination of alloreactive T cells, prevention of GVHD, and improvement of donor T-cell reconstitution.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-10231140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-10792004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-10891472,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-11062503,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-11135619,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-11222394,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-11447288,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-11581400,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-12070279,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-12070280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-12239180,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-12469278,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-12669018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-12808452,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-1294569,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-1467511,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-14978141,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-15728519,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-15931364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-16818678,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-17138819,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-18011,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-1969878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-1994250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-2053706,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-2663018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-2788053,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-2964497,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-7552996,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-7699333,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-7930609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-7964471,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-8240742,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-8415665,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-8462096,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-8648103,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-8781449,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-8955178,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-9252127,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-9520449,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-9751749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17595335-9864155
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-4971
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2803-10
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17595335-Animals,
pubmed-meshheading:17595335-Antibodies, Monoclonal,
pubmed-meshheading:17595335-Antibody Formation,
pubmed-meshheading:17595335-Bone Marrow Transplantation,
pubmed-meshheading:17595335-Female,
pubmed-meshheading:17595335-Graft vs Host Disease,
pubmed-meshheading:17595335-Immunophenotyping,
pubmed-meshheading:17595335-Male,
pubmed-meshheading:17595335-Mice,
pubmed-meshheading:17595335-Mice, Mutant Strains,
pubmed-meshheading:17595335-Receptors, Interleukin-7,
pubmed-meshheading:17595335-T-Lymphocytes,
pubmed-meshheading:17595335-Thymus Gland,
pubmed-meshheading:17595335-Transplantation, Homologous
|
pubmed:year |
2007
|
pubmed:articleTitle |
Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.
|
pubmed:affiliation |
Division of Stem Cell Transplantation, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|